Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552236 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Artificial intelligence in gastrointestinal cancers: diagnostic, prognostic, and surgical strategies.
Cancer Lett
January 2025
School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
GI (Gastrointestinal) malignancies are one of the most common and lethal cancers globally. The dawn of precision medicine and developing technologies have reduced the mortality rates for GI malignancies, underscoring the main role of early detection methods for survival rate improvement. Artificial intelligence (AI) is a new technology that may improve GI cancer screening, treatment, and therapeutic efficiency for better patient care.
View Article and Find Full Text PDFWhen Leaders Don't Walk the Walk: A National Survey of Academic Nurse Leader Perceptions of Staff Burnout.
Nurs Educ Perspect
November 2024
About the Authors Adrienne Martinez-Hollingsworth, PhD, MSN, RN, PHN, WAN, is director of research and evaluation, AltaMed Institute for Health Equity, and assistant project scientist, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California. Dawn Goodolf, PhD, RN, is associate dean, Helen S. Breidegam School of Nursing and Public Health, and associate professor, Moravian University, Bethlehem, Pennsylvania. Nia Martin, PhD, MSN, RN, is assistant professor, Loma Linda University School of Nursing, Loma Linda, California. Linda Kim, PhD, RN, PHN, is research scientist, Department of Nursing Research, and assistant professor of medicine, Cedars Sinai Medical Center, Los Angeles, California. Jennifer Saylor, PhD, APRN, ACNS-BC, is associate dean for faculty and student affairs and associate professor, School of Nursing, University of Delaware, Newark, Delaware. Jennifer Evans, DNP, RN, NC-BC, is assistant dean and associate professor, University of Southern Indiana College of Nursing and Health Professions, Evansville, Indiana. Annette Hines, PhD, RN, is the Executive Director of the Susan S. Morrison School of Nursing, University of St. Thomas. Jin Jun, PhD, RN, is assistant professor, Center for Healthy Aging, Self-Management and Complex Care, College of Nursing, Ohio State University, Columbus, Ohio. The first author received a travel stipend from HRSA 22-109 Health and Public Safety Workforce Resiliency Training Program (U3NHP45414).The authors are grateful to Beth Speidel and Delsa Richards for their engagement and feedback. For more information, contact Adrienne Martinez-Hollingsworth at
Aim: This survey explored nurse leaders' impressions of burnout on college/school of nursing (CON/SON) administrative staff and leadership-facilitated strategies used to promote resilience building/mitigate burnout.
Background: Administrative staff are foundational to the success of a university's CON/SON, yet few studies have explored the impact of burnout in this group.
Method: Cross-sectional survey distributed to associate dean and business officer attendees of the 2022 American Association of Colleges of Nursing, Business Officers of Nursing Schools meeting (summer 2022) (n = 64).
Intravascular Coronary Imaging.
J Soc Cardiovasc Angiogr Interv
December 2024
Philips Healthcare, San Diego, California.
Circulating tumor DNA: the dawn of new, clinically scalable biomarkers for thromboembolism.
J Thromb Haemost
January 2025
Department of Medicine, Memorial Sloan Kettering Cancer Center. Electronic address:
Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawn.
J Neurol
January 2025
Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
The first of several phase 3 trials examining efficacy in relapsing MS has not been able to demonstrate a significant benefit and has also raised important safety concerns. More results are on their way and it will be important to understand whether the safety signals identified are drug- or class-specific and whether other BTKi also fail to reach their endpoints for relapsing MS. However, as reported in preliminary data for another BTKi, it may be that they will have more of a role in progressive disease as hinted by the unraveling of relevant molecular mechanisms and pathways.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!